Join
Live feed
·
PRReleasevia Quantisnow
Roivant Sciences Ltd. logo

Roivant Announces Positive Results for Batoclimab Myasthenia Gravis (MG) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Studies

ByQuantisnow·Wall Street's wire, on your screen.
ROIV· Roivant Sciences Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ROIV (Roivant Sciences Ltd.) and more on Quantisnow.